Last reviewed · How we verify
chitosan nanoparticles gel
At a glance
| Generic name | chitosan nanoparticles gel |
|---|---|
| Also known as | CSNPs, chitosan |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Antibacterial Effect of Two Different Intracanal Medicaments and Their Effect on Post-operative Pain (PHASE4)
- A Comparative Study Between the Efficacy of Diode Laser and Nano-chitosan Gel on Activation of Non-vital in- Office Bleaching Agent (PHASE1)
- The Proposed Study Aims to Investigate the Efficacy of Quercetin as an Adjunctive to Mechanical Debridement in Treatment of Periodontitis (PHASE2)
- Extracorporeal Shockwave Versus Phonophoresis Using Chitosan-Nanoparticles Gel on Functional and Anatomical Changes Detected With Artificial Intelligence Based Texture Analysis Algorithm in Knee Osteoarthritis Patients: A Double Blind Randomized Controlled Trial (NA)
- Antimicrobial Efficacy of Nano-Based ICM on E.F (NA)
- The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles (PHASE1)
- Effect of Chitosan Phonophoresis On Cubital Tunnel Syndrome (NA)
- PLGA Nanoparticles Entrapping Ciprofloxacin to Treat E-Fecalis Infections in Endodontics (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- chitosan nanoparticles gel CI brief — competitive landscape report
- chitosan nanoparticles gel updates RSS · CI watch RSS
- Ain Shams University portfolio CI